Drawbridge Anesthetic Beats Propofol In Early Trial
This article was originally published in PharmAsia News
Executive Summary
Drawbridge Pharmaceuticals said its Phaxan (alphaxalone) has proved successful in a Phase I trial as an alternative to propofol, currently the standard anesthesia drug.